Investigating Immune Escape by SARS-CoV-2 Variants
NCT05171803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38
Last updated 2023-11-08
Summary
The purpose of this protocol is to investigate the ability of pre-existing immunity by natural infection or vaccination to prevent infections by emerging SARS-CoV-2 variants.
Conditions
- COVID-19; Immunity
Interventions
- OTHER
-
No intervention
No intervention, prospective, cohort study.
Sponsors & Collaborators
-
Advarra
collaborator INDUSTRY -
University of California, Los Angeles
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-29
- Primary Completion
- 2022-12-31
- Completion
- 2023-10-15
Countries
- United States
Study Locations
More Related Trials
-
Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)
NCT04355351 ·Status: COMPLETED ·Phase: NA
-
Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study
NCT04888793 ·Status: COMPLETED
-
Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra
NCT05172167 ·Status: UNKNOWN
-
Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
NCT05315583 ·Status: TERMINATED ·Phase: NA
-
Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives.
NCT05655351 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
NCT04448145 ·Status: RECRUITING
-
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19
NCT04355533 ·Status: COMPLETED ·Phase: NA
-
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
NCT04750720 ·Status: COMPLETED ·Phase: NA
-
Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19
NCT04518969 ·Status: COMPLETED ·Phase: NA
-
SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19
NCT04979871 ·Status: COMPLETED
-
Changes in Cellular Immune Profile During COVID-19 Infection
NCT04470999 ·Status: SUSPENDED ·Phase: NA
-
Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 Infection
NCT05000307 ·Status: COMPLETED ·Phase: NA
-
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
NCT05774093 ·Status: RECRUITING
-
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19
NCT04418206 ·Status: COMPLETED ·Phase: NA
-
COVID-19 in PID Survey
NCT04459689 ·Status: RECRUITING
-
Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain
NCT05087277 ·Status: UNKNOWN
-
Immunogenicity Against SARS-CoV-2 in COVID-19 Close Contacts
NCT05094635 ·Status: UNKNOWN
-
The Influence of Histo-blood Group Antigen Polymorphism on the Composition of the Microbiota
NCT02349932 ·Status: WITHDRAWN
-
Study of the Incidence of SARS-CoV-2 Infection (COVID-19)
NCT04429594 ·Status: RECRUITING ·Phase: NA
-
Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children
NCT04490811 ·Status: UNKNOWN
-
Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024
NCT06683937 ·Status: NOT_YET_RECRUITING
-
Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection
NCT00450632 ·Status: COMPLETED
-
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C
NCT04588363 ·Status: COMPLETED
-
Immunology of the Infection Perinatal
NCT01055873 ·Status: COMPLETED
-
COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children
NCT04448717 ·Status: COMPLETED